Exploring Active Compounds and Mechanisms of Angong Niuhuang Wan on Ischemic Stroke Based on Network Pharmacology and Molecular Docking

<div>(a) Action mode of quercetin with target IL-6. (b) Action mode of <i>β</i>-estradiol with target AKT1. (c) Action mode of berberine with target MAPK3. (d) Action mode of wogonin with target PIK3CA. (e) Action mode of <i>β</i>-sitosterol with target TNF.</div>

Evidence-Based Complementary and Alternative Medicine

fig9

Figure 9

Figure 9: Exploring Active Compounds and Mechanisms of Angong Niuhuang Wan on Ischemic Stroke Based on Network Pharmacology and Molecular Docking 